Abstract
Objective: To define the best conditions foramniotic membrane preparation, storage and banking in its use for cornealreconstruction.Methods: Amniotic membrane pieces were prepared understerile conditions from placentas selected on the basis of donor medical andsocial history, serology, microbiological tests and histology. The pieces werekept at −140 °C but before grafting they werethawed and stored at 4 °C in RPMI medium, to have apreparation usable within 72 h. This procedure was validatedby testing its therapeutic effectiveness in 25 patients 13 of which had cornealulcers of various origin, 3 had sequelae of herpes simplex keratitis, 3 bandkeratopathy and 6 corneal stem cell deficiency due to chemical or thermalburns.Results: The preparation showed appreciableanti-inflammatory and analgesic effects. In the absence of corneal stem celldeficiency a stable re-epithelialisation was achieved in 15 out of 19 patients.When the limbus was lesioned, the amniotic membrane decreased vascularizationand increased the number of corneal epithelial cells only in 1 of the 6patients. No adverse reactions attributable to the tissue were recorded.Conclusions: A ready-to-use amniotic membrane preparationstored at 4 °C after cryopreservation has been tested incorneal reconstruction. Like the amniotic membrane thawed immediately beforegrafting, this preparation displayed full therapeutic effect in epithelialdefects with stromal ulceration but without severe limbal stem cell deficiency.In two years banking activity 463 pieces of the preparation were successfullydistributed to 90 Italian hospitals.
Similar content being viewed by others
References
Anderson D.F.,Ellies P.,Pires R.T.F. andTseng S.C.G. 2001. Amniotic membrane transplantation for partial limbal stem cell deficiency. Br. J. Ophthalmol. 85: 567–575.
Annas G.J. 1999. Waste and longing. The legal status of placental-blood banking. The New England J. Med. 340: 1521–1524.
Armitage W.J. andMoss S.J. 1990. Storage of corneas for trans plantation. In: Easty D.L. (ed.), Current Ophthalmic Surgery. Ballière Tindall, London, UK, pp. 193–199.
Azuara-Blanco A.,Pillai C.T. andDua H.S. 1999. Amniotic membrane transplantation for ocular surface reconstruction. Br. J. Ophthalmol. 83: 399–402.
Basti S. andRao S.K. 2000. Current status of limbal conjunctival autograft. Curr. Opinion Ophthalmol. 11: 224–232.
Chen H.J.,Pires R.T.F. andTseng S.C.G. 2000. Amniotic membrane transplantation for severe neurotrophic corneal ulcers. Br. J. Ophthalmol. 84: 826–833.
de Rotth A. 1940. Plastic repair of conjunctival defects with fetal membrane. Arch. Ophthalmol. 23: 522–525.
Dua H.S. andAzuara-Blanco A. 1999. Amniotic membrane transplantation. Br. J. Ophthalmol. 83: 748–752.
Ginsberg S.P. andBrightbill F.S. 1999. Central cornea thinning and perforation. In: Brightbill F.S. (ed.), Corneal surgery. Theory Technique Tissue. Mosby, St Louis, Missouri, USA, pp. 457–469.
Hao Y.,Ma D.H.,Hwang D.G.,Kim W.S. andZhang F. 2000. Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane. Cornea 19: 348–352.
Kim J.C. andTseng S.C.G. 1995. Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea 14: 473–484.
Koizumi N.J.,Inatomi T.J.,Sotozono C.J.,Fullwood N.J.,Quantock A.J. andKinoshita S. 2000. Growth factor mRNA and protein in preserved human amniotic membrane. Curr. Eye Res. 20: 173–177.
Kruse F.E.,Joussen A.M.,Rohrschneider K.,You L.,Sinn B.,Baumann J. et al. 2000. Cryopreserved human amniotic membrane for ocular surface reconstruction. Graefes Arch. Clin. Exp. Opthalmol. 20: 173–177.
Kruse F.E.,Rohrschneider K. andVolcker H.E. 1999. Multilayer amniotic membrane transplantation for reconstruction of deep corneal ulcers. Ophthalmology 106: 1504–1511.
Lambiase A.,Manni L.,Bonini S.,Rama P.,Micera A. andAloe L. 2000. Nerve growth factor promotes corneal healing: structural, biochemical and molecular analyses of rat and human corneas. Invest. Ophthalmol. Visual Sci. 41: 1063–1069.
Lavery F.S. 1946. Lime burn of conjunctiva and cornea treated with amnioplastin graft. Trans. Ophthalmol. Soc. UK 66: 668.
Lee S.H. andTseng S.C.G. 1997. Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am. J. Ophthalmol. 123: 3903–312.
Ljubimov A.V.,Burgeson R.E.,Butkowski R.J.,Michael A.F.,Sun T.T. andKenney M.C. 1995. Human corneal basement membrane heterogeneity: topographical differences in the expression of type IV collagen and laminin isoforms. Lab. Invest. 72: 461–473.
Meller D.,Pires R.T.,Mack R.J.,Figueiredo F.,Heiligenhaus A.,Park W.C. et al. 2000. Amniotic membrane transplantation for acute chemical or thermal burns. Ophthalmology 107: 980–990.
Mejia L.F.,Acosta C. andSantamaria J.P. 2000. Use of non preserved human amniotic membrane for the reconstitution of the ocular surface. Cornea 19: 288–291.
Park W.C. andTseng S.C.G. 2000. Modulation of acute inflammation and keratocyte death by suturing, blood, and amniotic membrane in PRK. Invest. Ophthalmol. Visual Sci. 41: 2906–2914.
Prabhasawat P.,Kosrirukvongs P.,Booranapong W. andVajaradul Y. 2000. Application of preserved human amniotic membrane for corneal surface reconstruction. Cell and Tissue Banking 1: 213–222.
Schermer A.,Galvin S. andSun T.T. 1986. Differentiation-related expression of major corneal keratin in vivo and in culture suggests limbal location of corneal epithelial stem cells. J. Cell Biol. 103: 49–62.
Shimazaki J.,Yang H.Y. andTsubota K. 1997. Amniotic membrane transplantation for ocular surface reconstruction in patients with chemical and thermal burns. Ophthalmology 104: 2068–2076.
Shimmura S.,Shimazaki J.,Ohashi Y. andTsubota K. 2001. Antiinflammatory effects of amniotic membrane transplantation in ocular surface disorders. Cornea 20: 408–413.
Sorsby A.,Haythorne J. andReed H. 1947. Further experience with amniotic membrane grafts in caustic burns of the eye. Br. J. Ophthalmol. 31: 409–418.
Sorsby A. andSymmons H.M. 1946. Amniotic membrane grafts in caustic burns. Br. J. Ophthalmol. 30: 337–345.
Talmi Y.P.,Sigler L. andInge E. 1991. Antibacterial properties of human amniotic membranes. Placenta 12: 285–288.
Tripathi B.J.,Kwait P.S. andTripathi R.C. 1990. Corneal growth factors: a new generation of ophthalmic pharmaceuticals. Cornea 9: 2–9.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rama, P., Giannini, R., Bruni, A. et al. Further evaluation of amniotic membrane banking for transplantation in ocular surface diseases. Cell Tissue Banking 2, 155–163 (2001). https://doi.org/10.1023/A:1020158206073
Issue Date:
DOI: https://doi.org/10.1023/A:1020158206073